The QGPRS Study: Qatar Genome Polygenic Risk Score, a precision Medicine Approach to Prevent Diabetic Complications in the affected Qatari Individuals
Dr. Ammira Al-Shabeeb Akil
Active Award
Sidra Medicine
3
PPM 03-0314-190024
Precision Pharmacogenomics in Qatar
Dr. Amal robay
Active Award
Weill Cornell Medical College in Qatar
4
PPM 03-0322-190036
Personalizing Therapy for Atrial Fibrillation in Qataris
Dr. Nidal Asaad
Active Award
Hamad Medical Corporation
5
PPM 03-0324-190038
Personalized care for Qatari patients with genetic predisposition to hypercholesterolaemia: better prediction, diagnosis and management
Prof. Omar Albagha
Award Active
Hamad Bin Khalifa University
6
PPM 04-0128-200014
Pharmacogenetics in childhood acute lymphoblastic leukemia: from variants identification to clinical implementation.
Dr. NAIMA AL-MULLA
Award Active
Sidra Medicine
7
PPM 04-0128-200015
Unlocking precision medicine potential through functional genomic studies in the diagnosis of inherited immunodeficiency diseases.
Dr. Amel Hassan
Award Active
Sidra Medicine
8
PPM 04-0131-200019
Early diagnosis of proteinopathies using massively parallel nano-spectroscopy with single-molecule sensitivity. Advanced clinical diagnostics for the development of personalized treatments
Prof. Milivoj Belic
Award Active
Texas A&M University at Qatar
9
PPM 04-0311-200035
Exploring Drug Resistance Mechanisms in Triple Negative Breast Cancers: From Patient Derived Organoids towards Precision Medicine
Prof. Lotfi Chouchane
Award Active
Weill Cornell Medical College in Qatar
10
PPM 04-0312-200037
Pharmacogenomics of TNF inhibitors in autoimmune diseases
Dr. Borbala Mifsud
Award Active
Hamad Bin Khalifa University
11
PPM 05-0316-210001
Multiregional genomic sequencing of pediatric cancer patients from Qatar, solid tumor heterogeneity and clinical impact
Dr. Wouter Hendrickx
Award Active
Sidra Medicine
12
PPM 05-0419-210008
Mendelian forms of Inflammatory Bowel Disease: Identifying the Genomic and Immunologic Drivers of Intestinal Inflammation
Dr. Bernice Lo
Award Active
Sidra Medicine
13
PPM 05-0423-210009
Target and drug discovery for cardiovascular genomic medicine using high-throughput cell screening platform
Dr. Ayman Al Haj Zen
Award Active
Hamad Bin Khalifa University
14
PPM 05-0506-210017
Artificial Intelligence and Precision Lifestyle Medicine: Unlocking the complex relationship between genes and environment
Dr. Mohammed Al-Thani
Award Active
Ministry of Public Health
15
PPM1-0102-160028
Genetic VERSUS Environmental Basis for Familial Diabetes in Qatar
Prof. Abdul-Badi Abou-Samra
Award Tech. Completed
Hamad Medical Corporation
16
PPM1-1122-150008
Mapping the population transcriptome for the Pilot phase of the Qatar Genome Project: Towards elucidating the causal functional consequences of Qatari genetic variation
Dr. Younes Mokrab
Award Tech. Completed
Sidra Medicine
17
PPM1-1206-150013
Personalized approach to muscle and neuromuscular genetic diseases in Qatar: Paths from clinical genetics and genomic signature research to preventive and precision medicine
Prof. Alice Abd El Aleem
Award Tech. Completed
Weill Cornell Medical College in Qatar
18
PPM1-1220-150017
A platform for large-scale serological profiling of the Qatari population to link individual genome and immune phenotype variation in health and disease
Dr. Nico Marr
Award Tech. Completed
19
PPM1-1229-150022
A high resolution map of structural variation in Qatari genomes and their contribution to quantitative traits and disease
Dr. Khalid Fakhro
Award Tech. Completed
Sidra Medicine
20
PPM2-0207-170010
Identification of genetic variants associated with polycystic ovary syndrome
Prof. Steven Hunt
Award Terminated
Weill Cornell Medical College in Qatar
21
PPM2-0216-170012
Saliva diagnostics to pave the way towards personalized medicine
Dr. Souhaila Al Khodor
Award Active
Sidra Medicine
22
PPM2-0216-170014
Genomics, Islamic Ethics and Public Engagement (GIEPE): Towards Bridging the Knowledge and Communication Gaps
Dr. Mohammed Ghaly
Award Active
Hamad Bin Khalifa University
23
PPM2-0226-170020
Qatar Epigenome: Profiling of Epigenetic modifications and identification of Epigenome Wide predictors of Type 2 Diabetes and Obesity in Qataris from the QGP pilot study.
